Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Metabolic Syndrome: A Ticking Time Bomb

01.12.2004


EU research to tackle the problem



Both obesity and type 2 diabetes have become global epidemics over recent decades bringing, in their wake, a number of metabolic symptoms and cardiovascular disease risk factors. Both of these disorders, however, are just the tip of the iceberg, being just two manifestations of the metabolic syndrome (see notes to editors) which has been suggested to affect 25% of the adult population in countries such as the UK, and has severe consequences for both public health and the economy. Research is being conducted across Europe to help tackle the metabolic syndrome and its
associated complications.

Between 10-20% of men and 10-25% of women in Europe are obese and by the year 2010, it is estimated that as many as 31 million people across Europe will need treatment for diabetes and related complications. Many of these people will display symptoms of the metabolic syndrome.



The rising prevalence of the metabolic syndrome needs to be tackled with urgency in order to prevent a public health catastrophe and huge costs to the health service and economy across Europe. Tackling the metabolic syndrome will require a huge and integrated societal effort.

Research is under way across Europe to establish the role of diet in the development of the metabolic syndrome and ways in which its prevalence and associated complications can be reduced, through the foods and diet that we eat. This research is being conducted by a pan European consortium of 24 research partners and is known as the Lipgene project (see notes to editors).

Our diets influence risk of developing chronic disease by interacting with the genes we have inherited (our genotype). For this reason, the genetic susceptibility for the metabolic syndrome is being determined, along with the role that diet, especially dietary fat, plays in the aetiology of the condition.

It is believed that changing the fatty acid composition of the diet, by replacing foods high in saturated fat (associated with an increased risk of heart disease) with foods high in unsaturated fat and increasing intakes of long-chain omega-3 fatty acids (i.e. DHA and EPA present in large amounts in oily fish) is a crucial step to help achieve a reduction in the prevalence and burden of the metabolic syndrome. But fish stocks are limited and not everyone likes oily fish. For example, in the UK around 60% of people typically don’t eat it and average weekly intake is about a third of a serving per person. Therefore, an alternative and sustainable source of long chain omega-3 fatty acids is needed to ensure optimal dietary intakes are achieved.

Innovative and cutting edge technology is being used in Lipgene to develop foods with modified fat compositions; for example, milks with a more unsaturated fatty acid profile and plant oils containing long chain omega-3 fatty acids. Such foods have the potential to play an invaluable role, in the future, in the battle against the rising tide of the metabolic syndrome, type 2 diabetes and cardiovascular disease, without consumers having to make major changes to their dietary habits. However, for novel foods to have an impact they must first be accepted by consumers. Acceptability of such food products will be explored. The cost implications of their production will be compared with the total costs to the EU economy of treating the metabolic syndrome and its complications.

A one-day conference is being held in London, on December 1st, to discuss the consequences of the metabolic syndrome, the Lipgene project and ways in which the metabolic syndrome can be tackled in terms of the food we eat.

Duty Editor | alfa
Further information:
http://www.nutrition.org.uk

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>